<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-14T11:17:02+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>这一次，医药人在自觉捍卫创新</title>
    <updated>2020-11-14T07:20:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/UYSlBEfHReJvN2cde5QNRw</id>
    <link href="https://mp.weixin.qq.com/s/UYSlBEfHReJvN2cde5QNRw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Vlog | 创联盟，秀合作，看赛诺菲中国如何加码数字化创新</title>
    <updated>2020-11-14T07:20:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/ykAcJ8-tD_rp0J8Fur71Yg</id>
    <link href="https://mp.weixin.qq.com/s/ykAcJ8-tD_rp0J8Fur71Yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昆药集团IDH1选择性抑制剂创新药获NMPA临床试验批准</title>
    <updated>2020-11-14T07:20:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/rFU4374jIC6O3wRJZpfSNQ</id>
    <link href="https://mp.weixin.qq.com/s/rFU4374jIC6O3wRJZpfSNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国创新药对外交易4.0模式到来！礼来再次重金砸向中国创新药企，但这次是核心技术！</title>
    <updated>2020-11-13T19:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/0eyBvJh5_dqkl4NX_iDFFQ</id>
    <link href="https://mp.weixin.qq.com/s/0eyBvJh5_dqkl4NX_iDFFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【投资人观点】创新药与泡沫共舞！泡沫里面，我们要做点什么？</title>
    <updated>2020-11-13T19:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/YsxojkuMPRNXGHJU2y7xAQ</id>
    <link href="https://mp.weixin.qq.com/s/YsxojkuMPRNXGHJU2y7xAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>200讲者对话2000企业家科学家投资家：未来十年，创新将重构整个产业！</title>
    <updated>2020-11-13T19:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/BCmk5ZHSNM1x09j5Uo9XCA</id>
    <link href="https://mp.weixin.qq.com/s/BCmk5ZHSNM1x09j5Uo9XCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国医师公益大会“全民健康传播行动”启动</title>
    <updated>2020-11-13T19:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/KTxx9hqn_sBDGV5prbUyGA</id>
    <link href="https://mp.weixin.qq.com/s/KTxx9hqn_sBDGV5prbUyGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>推动解决“卡脖子”问题，提升产业链供应链现代化水平，2020启思会有这三大动作</title>
    <updated>2020-11-13T19:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/TgpnWl9fhkFP6shF5dDBHg</id>
    <link href="https://mp.weixin.qq.com/s/TgpnWl9fhkFP6shF5dDBHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞进军糖尿病领域，医药一哥慢病板块将步入收获期！</title>
    <updated>2020-11-12T21:26:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/t6PVJnRPIjd4K-HS71j4Sg</id>
    <link href="https://mp.weixin.qq.com/s/t6PVJnRPIjd4K-HS71j4Sg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“下一个”PD-1会在哪？ 信达、天境、康方冲在CD47的路上</title>
    <updated>2020-11-12T21:26:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/qAcDt3rAfWmX3-DGS2565Q</id>
    <link href="https://mp.weixin.qq.com/s/qAcDt3rAfWmX3-DGS2565Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国生物制药抓住黄金机遇，龙头企业纷纷落户瑞士巴塞尔大区</title>
    <updated>2020-11-12T21:26:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/U5ARTFitHUHokP6XtNfprg</id>
    <link href="https://mp.weixin.qq.com/s/U5ARTFitHUHokP6XtNfprg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药师帮双11携哈药、合生元、豪森等药企刷新直播新纪录！</title>
    <updated>2020-11-12T21:26:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/HmJ9gpNGf5gDuzj4Kuzreg</id>
    <link href="https://mp.weixin.qq.com/s/HmJ9gpNGf5gDuzj4Kuzreg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>推动解决“卡脖子”问题，提升产业链供应链现代化水平，2020启思会有这三大动作</title>
    <updated>2020-11-12T21:26:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/ivZo0axPcmlrdQhSXv2mhA</id>
    <link href="https://mp.weixin.qq.com/s/ivZo0axPcmlrdQhSXv2mhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济、君实、信达……外国人眼中的中国十大Biotech还有谁？</title>
    <updated>2020-11-11T22:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/FUoX7Ye0Kz86BFwD9xrp0Q</id>
    <link href="https://mp.weixin.qq.com/s/FUoX7Ye0Kz86BFwD9xrp0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴“二次创业”第一步：与医联达成深度战略合作。他们要做什么？</title>
    <updated>2020-11-11T22:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/rlvzf9WlWdkk8y7El2DFMw</id>
    <link href="https://mp.weixin.qq.com/s/rlvzf9WlWdkk8y7El2DFMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>雅培等多家MNC进博会密集签约背后，这一信号值得关注！</title>
    <updated>2020-11-11T22:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/HdpofwpPdsABrqONTzelSQ</id>
    <link href="https://mp.weixin.qq.com/s/HdpofwpPdsABrqONTzelSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保目录调整有了最新进展！如何看待僵尸药、活跃药和增补药品的问题与机遇？</title>
    <updated>2020-11-11T22:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/Y_DmqTh7qnbm532lMj9h9g</id>
    <link href="https://mp.weixin.qq.com/s/Y_DmqTh7qnbm532lMj9h9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>27个药品无法保障供应，两年内禁止参与集采！大量三批集采品种未申报降价！</title>
    <updated>2020-11-11T22:01:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/qbAvj1q99G2byk4tTOeBkg</id>
    <link href="https://mp.weixin.qq.com/s/qbAvj1q99G2byk4tTOeBkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不吹不黑！辉瑞疫苗“炸”完，接下来会怎样？产能和冷链挑战何解？</title>
    <updated>2020-11-10T23:50:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/h0JhI795L1WBgWpa-7cvuQ</id>
    <link href="https://mp.weixin.qq.com/s/h0JhI795L1WBgWpa-7cvuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>推出中国2030战略，这家跨国药企升级在华目标</title>
    <updated>2020-11-10T23:50:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/KdonQBK6zRdHXtHCoIOP4Q</id>
    <link href="https://mp.weixin.qq.com/s/KdonQBK6zRdHXtHCoIOP4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>